VALNEVA USA, INC. for VALNEVA USA, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to research and development for infectious disease vaccines, medical coverage of travel and occupational vaccines, biopreparedness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMANDA ARNOLD New | Senator Tester, legislative staff 2006-2009 |
| JOHN KANARAS New | — |
Pharmacy PHA
Issues related to research and development for infectious disease vaccines, medical coverage of travel and occupational vaccines, biopreparedness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMANDA ARNOLD New | Senator Tester, legislative staff 2006-2009 |
| JOHN KANARAS New | — |
Science/Technology SCI
Issues related to research and development for infectious disease vaccines, medical coverage of travel and occupational vaccines, biopreparedness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMANDA ARNOLD New | Senator Tester, legislative staff 2006-2009 |
| JOHN KANARAS New | — |
Travel/Tourism TOU
Issues related to research and development for infectious disease vaccines, medical coverage of travel and occupational vaccines, biopreparedness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMANDA ARNOLD New | Senator Tester, legislative staff 2006-2009 |
| JOHN KANARAS New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| VALNEVA SE | France | France | 100.0% | — |
| VALNEVA AUSTRIA GMBH | Austria | Austria | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.